Pattern of amplification and overexpression of the eukaryotic initiation factor 4E gene in solid tumor

Journal of Surgical Research

Volumn 85, Issue 1, 1999, Pages 37-42

  Sorrells, Donald L ^a   Meschonat, Carol ^a   Black, Destin ^a   Li, Benjamin D L ^a  

^a Louisiana State University Health Sciences Center at Shreveport   (United States)

Author keywords

eIF4E; Malignant transformation; Oncogene; Solid tumor

Indexed keywords

INITIATION FACTOR 4E;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; INTRADUCTAL CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SOLID TUMOR;

EID: 0032775890     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1999.5653     Document Type: Article

References (25)

1. Rhoads R. Regulation of eukaryotic protein synthesis by initiation factors. J. Biol. Chem. 268:1993;3017.
2. Sonenberg N. mRNA 5′ cap-binding protein eIF-4E and control of cell growth. Hershey J., Mathews M., Sonenberg N. Translational Control. 1996;245-270 Cold Spring Harbor Laboratory Press, New York.
3. Jansen M., Moor C. D., Sussenbach J., Brande J. V. D. Translational control of gene expression. Pediatr. Res. 37:1995;681.
4. Rosenwald I., Lazaris-Karatzas A., Sonenberg N., Schmidt E. Elevated levels of cyclin D1 in response to increased expression of eukaryotic initiation factor 4E. Mol. Cell. Biol. 13:1993;7358.
5. DeBenedetti A., Graff J., Zimmer S. CHO cells transformed by the translational factor eIF4E display increased c-myc expression, but require overexpression of Max for tumorigenicity. Mol. Cell Differ. 2:1994;347.
6. Graff J., DeBenedetti A., Olson J., Tamez P., Casero R., Zimmer S. Translation of ODC mRNA and polyamine transport are suppressed in ras-transformed CREF cells by depleting translation initiation factor 4E. Biochem. Biophys. Res. Commun. 240:1997;15.
7. Kevil C., Carter P., Hu B., DeBenedetti A. Translational enhancement of FGF-2 by eIF-4 factors, and alternate utilization of CUG and AUG codons for translation initiation. Oncogene. 11:1995;2339.
8. Kevil C., DeBenedetti A., Payne D., Coe L., Laroux F., Alexander J. Translational regulation of vascular permeability factor by eukaryotic initiation factor 4E: Implications for tumor angiogenesis. Int. J. Cancer. 65:1996;785.
9. Brodeur G., Seeger R., Schwab M. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science. 224:1984;1121.
10. Slamon D., Godolphin W., Jones L. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science. 244:1989;707.
11. Sorrells, D, Ghali, G, Meschonat, C, Defatta, R, Black, D, Liu, L, DeBenedetti, A, Nathan, C, and, Li, B. Competitive PCR to detect eIF4E gene amplification in head and neck cancer, Head Neck, in press.
12. Sorrells D., Black D., Meschonat C., Rhoads R., DeBenedetti A., Gao M., Li B. Detection of eIF4E gene amplification in breast cancer by competitive PCR. Ann. Surg. Oncol. 5:1998;232.
13. Higuchi R. Using PCR to engineer DNA. Erlich H. PCR Technology: Principles and Applications for DNA Amplification. 1989;61-70 Stockton Press, New York.
14. Wang A., Mark D. Quantitative PCR. Innis M., Gelfand D., Sninsky J., White T. PCR Protocols: A Guide to Methods and Applications. 1990;70-75 Academic Press, San Diego.
15. Li B., Harlow S., Budnick R., Sheedy D., Stewart C. Detection of HER-2/neu oncogene amplification in flow cytometry-sorted breast ductal cells by competitive polymerase chain reaction. Cancer. 73:1994;2771.
16. Kerekatte V., Smiley K., Hu B., Smith A., Gelder F., DeBenedetti A. The proto-oncogene/translation factor eIF-4e: A survey of its expression in breast carcinomas. Int. J. Cancer. 64:1995;27.
17. Lazaris-Karatzas A., Sonenberg N. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′cap. Nature. 345:1990;544.
18. Graff J., Boghaert E., Benedetti A. D., Tudor D., Zimmer C., Chan S., Zimmer S. Reduction of translation initiation factor 4E decreases the malignancy of ras-transformed cloned rat embryo fibroblasts. Int. J. Cancer. 60:1995;255.
19. Anthony B., Carter P., DeBenedetti A. Overexpression of the proto-oncogene/translation factor 4E in breast carcinoma cell lines. Int. J. Cancer. 65:1996.
20. Nathan C., Liu L., Li B., Abreo F., Nandy I., DeBenedetti A. Detection of the proto-oncogene eIF4E in surgical margins may predict recurrence in head and neck cancer. Oncogene. 15:1997;579.
21. Li B., Liu L., Dawson M., DeBenedetti A. Overexpression of eukaryotic initiation factor 4E (eIF4E) in breast carcinoma. Cancer. 79:1997;2385.
22. DeFatta R., Turbat-Herrera E., Li B., Anderson W., DeBenedetti A. Elevated expression of eIF4E in confined early breast cancer lesions: Possible role of hypoxia. Int. J. Cancer. 80:1999;516.
23. Weidner N., Semple J., Welch W., Folkman J. Tumor angiogenesis and metastasis - Correlation in invasive breast carcinoma. N. Engl. J. Med. 324:1991;1.
24. Nathan C., Carter P., Liu L., Li B., Abreo F., Tudor A., Zimmer S., DeBenedetti A. Elevated expression of eIF4E and FGF-2 isoforms during vascularization of breast carcinomas. Oncogene. 15:1997;1087.
25. Li B., McDonald J., Nassar R., DeBenedetti A. Clinical outcome in stage I to III breast carcinoma and eIF4E overexpression. Ann. Surg. 227:1998;756.